ACARBOSE
- Product NDC
- 71335-1583
- 11-digit product format
- 713351583
- Labeler code
- 71335
- Product ID
- 71335-1583_6abd4ad4-4989-4403-a971-35dac770b2f4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ACARBOSE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA091343
- Marketing category
- ANDA
- Marketing start
- 2015-02-01
- Marketing end
- 0000-00-00
- Substance
- ACARBOSE
- Active strength
- 50 mg/1
- Pharmacologic classes
- alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71335-1583-1 | ACARBOSE | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
| 71335-1583-2 | ACARBOSE | 90 in 1 BOTTLE | TABLET | 90 | | 1 |
| 71335-1583-3 | ACARBOSE | 100 in 1 BOTTLE | TABLET | 100 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71335-1583 | ACARBOSE TABLET [BRYANT RANCH PREPACK] | 1 | Legacy NDC, 3 package rows | 20200924_c52016f3-98a0-455a-a1c8-0405b44208d7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-1583-1 | 71335158301 | 30 TABLET in 1 BOTTLE (71335-1583-1) | 30 tablet | 2020-04-27 | 0000-00-00 | No | No | Current |
| 71335-1583-2 | 71335158302 | 90 TABLET in 1 BOTTLE (71335-1583-2) | 90 tablet | 2020-04-27 | 0000-00-00 | No | No | Current |
| 71335-1583-3 | 71335158303 | 100 TABLET in 1 BOTTLE (71335-1583-3) | 100 tablet | 2020-04-27 | 0000-00-00 | No | No | Current |